| Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase. Zhang Q., Gu J., Li L., Liu J., Luo B., Cheung H.W., Boehm J.S., Ni M., Geisen C., Root D.E. et al.
Cancer Cell 16:413-424(2009) · Mapped (11) |
| Single-nucleotide polymorphisms and expression of IL23R in Chinese ankylosing spondylitis patients. Wang X., Huang J., Lin Z., Liao Z., Li C., Wei Q., Jiang Y., Zhao L., Gu J.
Rheumatol. Int. 0:0-0(2009) · Mapped (23) |
| Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Wu X., Ye Y., Kiemeney L.A., Sulem P., Rafnar T., Matullo G., Seminara D., Yoshida T., Saeki N., Andrew A.S. et al.
Nat. Genet. 41:991-995(2009) · Mapped (1) |
| Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants. Wu X., Spitz M.R., Lee J.J., Lippman S.M., Ye Y., Yang H., Khuri F.R., Kim E., Gu J., Lotan R. et al.
Cancer Prev Res (Phila Pa) 2:617-624(2009) · Mapped (126) |
| Amyloid-beta induces a caspase-mediated cleavage of P2X4 to promote purinotoxicity. Varma R., Chai Y., Troncoso J., Gu J., Xing H., Stojilkovic S.S., Mattson M.P., Haughey N.J.
Neuromolecular Med. 11:63-75(2009) · Mapped (8) |
| Dietary intake of vegetables and fruits and the modification effects of GSTM1 and NAT2 genotypes on bladder cancer risk. Lin J., Kamat A., Gu J., Chen M., Dinney C.P., Forman M.R., Wu X.
Cancer Epidemiol. Biomarkers Prev. 18:2090-2097(2009) · Mapped (15) |
| CDK11p58 represses vitamin D receptor-mediated transcriptional activation through promoting its ubiquitin-proteasome degradation. Chi Y., Hong Y., Zong H., Wang Y., Zou W., Yang J., Kong X., Yun X., Gu J.
Biochem. Biophys. Res. Commun. 386:493-498(2009) · Mapped (16) |
| Oleic acid-induced ADRP expression requires both AP-1 and PPAR response elements, and is reduced by Pycnogenol through mRNA degradation in NMuLi liver cells. Fan B., Ikuyama S., Gu J.Q., Wei P., Oyama J., Inoguchi T., Nishimura J.
Am. J. Physiol. Endocrinol. Metab. 297:E112-23(2009) · Mapped (13) |
| HSP70 protects BCL2L12 and BCL2L12A from N-terminal ubiquitination-mediated proteasomal degradation. Yang J., Hong Y., Wang W., Wu W., Chi Y., Zong H., Kong X., Wei Y., Yun X., Cheng C. et al.
FEBS Lett. 583:1409-1414(2009) · Mapped (2) |
| Cystic fibrosis transmembrane conductance regulator expression in human spinal and sympathetic ganglia. Niu N., Zhang J., Guo Y., Yang C., Gu J.
Lab. Invest. 89:636-644(2009) · Mapped (46) |
| Autosomal-dominant cerulean cataract in a chinese family associated with gene conversion mutation in beta-B2-crystallin. Wang L., Lin H., Gu J., Su H., Huang S., Qi Y.
Ophthalmic Res. 41:148-153(2009) · Mapped (1) |
| Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas. Yu B., Yang X., Xu Y., Yao G., Shu H., Lin B., Hood L., Wang H., Yang S., Gu J. et al.
J. Hepatol. 50:948-957(2009) · Mapped (7) |
| Core fucosylation of E-cadherin enhances cell-cell adhesion in human colon carcinoma WiDr cells. Osumi D., Takahashi M., Miyoshi E., Yokoe S., Lee S.H., Noda K., Nakamori S., Gu J., Ikeda Y., Kuroki Y. et al.
Cancer Sci. 100:888-895(2009) · Mapped (7) |
| Small interfering RNA targeting the subunit ATP6L of proton pump V-ATPase overcomes chemoresistance of breast cancer cells. You H., Jin J., Shu H., Yu B., De Milito A., Lozupone F., Deng Y., Tang N., Yao G., Fais S. et al.
Cancer Lett. 280:110-119(2009) · Mapped (2) |
| Identification of the CLCN7 gene mutations in two Chinese families with autosomal dominant osteopetrosis (type II). Zhang Z.L., He J.W., Zhang H., Hu W.W., Fu W.Z., Gu J.M., Yu J.B., Gao G., Hu Y.Q., Li M. et al.
J. Bone Miner. Metab. 27:444-451(2009) · Mapped (13) |
| An N-glycosylation site on the beta-propeller domain of the integrin alpha5 subunit plays key roles in both its function and site-specific modification by beta1,4-N-acetylglucosaminyltransferase III. Sato Y., Isaji T., Tajiri M., Yoshida-Yamamoto S., Yoshinaka T., Somehara T., Fukuda T., Wada Y., Gu J.
J. Biol. Chem. 284:11873-11881(2009) · Mapped (9) |
| N-glycosylation of the I-like domain of beta1 integrin is essential for beta1 integrin expression and biological function: identification of the minimal N-glycosylation requirement for alpha5beta1. Isaji T., Sato Y., Fukuda T., Gu J.
J. Biol. Chem. 284:12207-12216(2009) · Mapped (4) |
| Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. Wang X., Lin Z., Wei Q., Jiang Y., Gu J.
Rheumatol. Int. 29:1343-1347(2009) · Mapped (3) |
| Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma. Wang H., Jiang H., Zhou M., Xu Z., Liu S., Shi B., Yao X., Yao M., Gu J., Li Z.
Cancer Lett. 279:30-38(2009) · Mapped (15) |
| Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers. Gu J., Pauer G.J., Yue X., Narendra U., Sturgill G.M., Bena J., Gu X., Peachey N.S., Salomon R.G., Hagstrom S.A. et al.
Mol. Cell Proteomics 8:1338-1349(2009) · Mapped (14) |
| Requirement of Fut8 for the expression of vascular endothelial growth factor receptor-2: a new mechanism for the emphysema-like changes observed in Fut8-deficient mice. Wang X., Fukuda T., Li W., Gao C.X., Kondo A., Matsumoto A., Miyoshi E., Taniguchi N., Gu J.
J. Biochem. 145:643-651(2009) · Mapped (17) |
| Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria. Xu L., Xiao N., Liu F., Ren H., Gu J.
Proc. Natl. Acad. Sci. U.S.A. 106:1530-1535(2009) · Mapped (13) |
| Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Ye Y., Wang K.K., Gu J., Yang H., Lin J., Ajani J.A., Wu X.
Cancer Prev Res (Phila Pa) 1:460-469(2008) · Mapped (44) |
| Trihydrophobin 1 Interacts with PAK1 and Regulates ERK/MAPK Activation and Cell Migration. Cheng C., Kong X., Wang H., Gan H., Hao Y., Zou W., Wu J., Chi Y., Yang J., Hong Y. et al.
J. Biol. Chem. 284:8786-8796(2009) · Mapped (12) |
| Repression of estrogen receptor alpha by CDK11p58 through promoting its ubiquitin-proteasome degradation. Wang Y., Zong H., Chi Y., Hong Y., Yang Y., Zou W., Yun X., Gu J.
J. Biochem. 145:331-343(2009) · Mapped (62) |
in Literature Citations
